Treatment of dyslipidemia in patients with diabetes mellitus.
The article reviews the key aspects of pathophysiology of diabetic dyslipidemia, its treatment and associated risk of cardiovascular complications. It examines the difference in lipid metabolism between type 1 and type 2 diabetes mellitus. The diagnostic values of particular lipid abnormalities as risk predictors for cardiovascular events are analyzed. Guidelines on hypolipemic treatment in diabetes are summarized and commented on. Standard and newly introduced methods as well as new opportunities of hypolipemic treatment are presented.
Pikto-Pietkiewicz
Witold
W
Department of Cardiology and Angiology, Miedzyleski Regional Hospital Warsaw, Bursztynowa 2, PL 04-749 Warszawa, Poland. wpp@tlen.pl
Wołkowska
Katarzyna
K
Pasierski
Tomasz
T
D000818:Animals; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D050171:Dyslipidemias / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology; D017410:Practice Guidelines as Topic; D012307:Risk Factors
D000960:Hypolipidemic Agents